Welltower (WELL) PT Raised to $83.00 at Morgan Stanley

Welltower (NYSE:WELL) had its price target lifted by Morgan Stanley from $77.00 to $83.00 in a research note released on Thursday, March 28th, AnalystRatings.com reports. They currently have an overweight rating on the real estate investment trust’s stock.

Other analysts have also recently issued reports about the company. Raymond James boosted their price target on Welltower from $75.00 to $78.00 and gave the stock an outperform rating in a research report on Tuesday, February 26th. They noted that the move was a valuation call. Mitsubishi UFJ Financial Group boosted their price target on Welltower to $82.00 and gave the stock an overweight rating in a research report on Wednesday, February 13th. Royal Bank of Canada boosted their price target on Welltower to $76.00 and gave the stock a sector perform rating in a research report on Thursday, February 21st. Scotiabank initiated coverage on Welltower in a research report on Monday, December 10th. They issued a sector perform rating and a $74.00 price objective on the stock. Finally, JPMorgan Chase & Co. raised Welltower from a neutral rating to an overweight rating in a research report on Wednesday, December 19th. Ten equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. Welltower currently has an average rating of Buy and an average target price of $71.29.

Shares of NYSE WELL traded up $0.98 during midday trading on Thursday, reaching $73.24. The company had a trading volume of 1,294,499 shares, compared to its average volume of 1,809,273. Welltower has a one year low of $49.58 and a one year high of $79.41. The company has a current ratio of 1.64, a quick ratio of 1.64 and a debt-to-equity ratio of 0.89. The firm has a market cap of $29.27 billion, a PE ratio of 18.17, a price-to-earnings-growth ratio of 3.10 and a beta of 0.46.

Welltower (NYSE:WELL) last announced its quarterly earnings results on Tuesday, February 12th. The real estate investment trust reported $1.01 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.03 by ($0.02). Welltower had a net margin of 17.14% and a return on equity of 6.28%. The business had revenue of $1.24 billion for the quarter, compared to analysts’ expectations of $1.26 billion. The business’s revenue was up 12.4% on a year-over-year basis. As a group, equities research analysts forecast that Welltower will post 4.18 earnings per share for the current fiscal year.

In other news, EVP Mercedes Kerr sold 5,000 shares of the company’s stock in a transaction on Thursday, February 28th. The stock was sold at an average price of $74.50, for a total value of $372,500.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.15% of the stock is owned by corporate insiders.

Large investors have recently bought and sold shares of the company. SG Americas Securities LLC purchased a new position in shares of Welltower during the third quarter valued at about $2,268,000. JPMorgan Chase & Co. purchased a new position in shares of Welltower during the third quarter valued at about $176,871,000. Janus Henderson Group PLC purchased a new position in shares of Welltower during the third quarter valued at about $10,323,000. Bank of New York Mellon Corp purchased a new position in shares of Welltower during the third quarter valued at about $405,367,000. Finally, American International Group Inc. purchased a new position in shares of Welltower during the third quarter valued at about $10,772,000. Hedge funds and other institutional investors own 84.87% of the company’s stock.

Welltower Company Profile

Welltower Inc (NYSE: WELL), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience.

Featured Story: Swap

Analyst Recommendations for Welltower (NYSE:WELL)

Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with MarketBeat.com's FREE daily email newsletter.